37 results
8-K
EX-4.1
VRPX
Virpax Pharmaceuticals Inc
17 May 24
Virpax Announces Pricing of $2.25 Million Public Offering
4:05pm
not entitle the Holder to any voting rights or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i
8-K
EX-4.2
VRPX
Virpax Pharmaceuticals Inc
17 May 24
Virpax Announces Pricing of $2.25 Million Public Offering
4:05pm
Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights or other rights as a stockholder of the Company prior
8-K
EX-4.3
VRPX
Virpax Pharmaceuticals Inc
17 May 24
Virpax Announces Pricing of $2.25 Million Public Offering
4:05pm
; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior
424B4
VRPX
Virpax Pharmaceuticals Inc
16 May 24
Prospectus supplement with pricing info
4:00pm
approval. Our board of directors may determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights … designations, rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges
PRE 14A
cjz 9eo40
21 Nov 23
Preliminary proxy
4:57pm
S-3
qhb4v33qovw2h7pdi
7 Oct 22
Shelf registration
5:01pm
424B4
3grhm4k95uibsy9px
15 Sep 21
Prospectus supplement with pricing info
4:31pm